RESUMEN
Disturbance of bone homeostasis caused by Mycobacterium tuberculosis (Mtb) is a key clinical manifestation in spinal tuberculosis (TB). However, the complete mechanism of this process has not been established, and an effective treatment target does not exist. Increasing evidence shows that abnormal osteoclastogenesis triggered by an imbalance of the receptor activator of NF-κB ligand (RANKL)/osteoprotegerin (OPG) axis may play a key role in the disturbance of bone homeostasis. Previous studies reported that RANKL is strongly activated in patients with spinal TB; however, the OPG levels in these patients were not investigated in previous studies. In this study, we investigated the OPG levels in patients with spinal TB and the dysregulation of osteoblasts caused by Mtb infection. Inhibition of the Mce4a gene of Mtb by an antisense locked nucleic acid (LNA) gapmer (Mce4a-ASO) was also investigated. Analysis of the serum OPG levels in clinical samples showed that the OPG levels were significantly decreased in patients with spinal TB compared to those in the group of non-TB patients. The internalization of Mtb in osteoblasts, the known major source of OPG, was investigated using the green fluorescent protein (GFP)-labeled Mycobacterium strain H37Ra (H37RaGFP). The cell-associated fluorescence measurements showed that Mtb can efficiently enter osteoblast cells. In addition, Mtb infection caused a dose-dependent increase of the CD40 mRNA expression and cytokine (interleukin 6, IL-6) secretion in osteoblast cells. Ligation of CD40 by soluble CD154 reversed the increased secretion of IL-6. This means that the induced CD40 is functional. Considering that the interaction between CD154-expressing T lymphocytes and bone-forming osteoblast cells plays a pivotal role in bone homeostasis, the CD40 molecule might be a strong candidate for mediating the target for treatment of bone destruction in spinal TB. Additionally, we also found that Mce4a-ASO could dose-dependently inhibit the Mce4a gene of Mtb and reverse the decreased secretion of IL-6 and the impaired secretion of OPG caused by Mtb infection of osteoblast cells. Taken together, the current finding provides breakthrough ideas for the development of therapeutic agents for spinal TB.
Asunto(s)
Mycobacterium tuberculosis , Tuberculosis Ganglionar , Tuberculosis de la Columna Vertebral , Humanos , Interleucina-6/metabolismo , Mycobacterium tuberculosis/metabolismo , Osteoblastos/metabolismo , Osteoclastos/química , Osteoclastos/metabolismo , Osteogénesis , Osteoprotegerina/metabolismo , Ligando RANK/metabolismo , Tuberculosis de la Columna Vertebral/metabolismoRESUMEN
Histochemical detection of tartrate-resistant acid phosphatase (TRAP) activity is a fundamental technique for visualizing osteoclastic bone resorption and assessing osteoclast activity status in tissues. This approach has mostly employed colorimetric detection, which has limited quantification of activity in situ and co-labelling with other skeletal markers. Here we report simple colorimetric and fluorescent TRAP assays in zebrafish and medaka, two important model organisms for investigating the pathogenesis of bone disorders. We show fluorescent TRAP staining, utilising the ELF97 substrate, is a rapid, robust and stable system to visualise and quantify osteoclast activity in zebrafish, and is compatible with other fluorescence stains, transgenic lines and antibody approaches. Using this approach, we show that TRAP activity is predominantly found around the base of the zebrafish pharyngeal teeth, where osteoclast activity state appears to be heterogeneous.
Asunto(s)
Fosfatasa Ácida , Osteoclastos , Fosfatasa Ácida/análisis , Animales , Colorimetría , Isoenzimas , Osteoclastos/química , Fosfatasa Ácida Tartratorresistente/análisis , Pez CebraRESUMEN
Osteoclast-mediated bioresorption can be an efficient means of incorporating the dissolution of biomaterials in the bone remodeling process. Because of the compositionally and structurally close resemblance of biomaterials with the natural mineral phases of the bone matrix, synthetic carbonate-substituted apatite (CA) is considered as an ideal biomaterial for clinical use. The present study therefore investigated the effects of electrical polarization on the surface characteristics and interactions with human osteoclasts of hydroxyapatite (HA) and CA. Electrical polarization was found to improve the surface wettability of these materials by increasing the surface free energy, and this effect was maintained for 1 month. Analyses of human osteoclast cultures established that CA subjected to a polarization treatment enhanced osteoclast resorption but did not affect the early differentiation phase or the adherent morphology of the osteoclasts as evaluated by staining. These data suggest that the surface characteristics of the CA promoted osteoclast resorption. The results of this work are expected to contribute to the future design of cell-mediated bioresorbable biomaterials capable of resorption by osteoclasts and of serving as a scaffold for bone regeneration.
Asunto(s)
Apatitas/metabolismo , Osteoclastos/metabolismo , Apatitas/química , Electricidad , Humanos , Ensayo de Materiales , Osteoclastos/química , Propiedades de Superficie , HumectabilidadRESUMEN
Uterine leiomyosarcoma (ULMS) with osteoclast-like giant cells (OLGCs) has been reported as a rare phenomenon in ULMS, and its clinico-pathological features and tumorigenesis remain unclear. We recently reported high expression of receptor activator of nuclear factor κB ligand (RANKL) in ULMS with OLGCs. As osteoblasts produce RANKL, in this study, we analyzed the expression of Runt-related transcription factor 2 (RUNX2), a critical transcription factor for osteoblasts, and osteoclast-related proteins in three cases of ULMS with OLGCs as well as five conventional ULMSs and nine leiomyomas. Immunohistochemistry and real-time reverse transcription quantitative polymerase chain reaction analyses showed high expression of RUNX2 and RANKL in ULMS with OLGCs. In these cases, macrophages expressed receptor activator of nuclear factor κB (RANK), and OLGCs expressed osteoclast-related proteins (nuclear factor of activated T cells, cytoplasmic 1 (NFATc1), and cathepsin K). Accumulation sites of cathepsin K-positive OLGCs showed hemorrhagic appearance and degraded type IV collagen. We reviewed reported cases of ULMS with OLGCs, including ours, and found that they presented an aggressive course even at stage I. Furthermore, metastatic lesions showed similar histological features to those of OLGC association in ULMS. Here, we show that tumor cells in ULMS with OLGCs highly express RUNX2 and RANKL and that osteoclastic differentiation of macrophages occurs in the tumor tissue.
Asunto(s)
Biomarcadores de Tumor/análisis , Subunidad alfa 1 del Factor de Unión al Sitio Principal/análisis , Células Gigantes/química , Leiomiosarcoma/química , Osteoclastos/química , Ligando RANK/análisis , Neoplasias Uterinas/química , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor/genética , Catepsina K/análisis , Diferenciación Celular , Subunidad alfa 1 del Factor de Unión al Sitio Principal/genética , Femenino , Células Gigantes/patología , Humanos , Leiomiosarcoma/genética , Leiomiosarcoma/secundario , Persona de Mediana Edad , Factores de Transcripción NFATC/análisis , Osteoclastos/patología , Fenotipo , Ligando RANK/genética , Regulación hacia Arriba , Neoplasias Uterinas/genética , Neoplasias Uterinas/patologíaRESUMEN
Undifferentiated carcinoma (UC) and undifferentiated carcinoma with osteoclast-like giant cells (UCOGC) are peculiar variants of pancreatic ductal adenocarcinoma (PDAC), characterized by hypercellularity and absence of glandular patterns. The inflammatory microenvironment is peculiar in UCOGC, since it is dominated by macrophages and osteoclast-like giant cells. However, from a molecular point of view, both UC and UCOGC are very similar to conventional PDAC, sharing alterations of the most common genetic drivers. Clinically, UC usually show a worse prognosis, whereas UCOGC may show a better prognosis if it is not associated with a PDAC component. To highlight potential biological differences between these entities, we investigated the role of the epithelial to mesenchymal transition (EMT) in UC and UCOGC. Specifically, we analyzed the immunohistochemical expression of three well-known EMT markers, namely Twist1, Snai2, and E-cadherin, in 16 cases of UCOGC and 10 cases of UC. We found that EMT is more frequently activated in UC (10/10 cases) than in UCOGC (8/16 cases; p = 0.05). Furthermore, in UCOGC, EMT was activated with a higher frequency in cases with an associated PDAC component. Snai2 was the most frequently and strongly expressed marker in both tumor types (10/10 UC, 8/16 UCOGC), and its expression was higher in UC than in UCOGC (mean immunohistochemical score: 4.8 in UC vs. 2.1 in UCOGC, p < 0.01). Our results shed new light on the biology of UC and UCOGC: EMT appeared as a more important process in UC, and Snai2 emerged as a central EMT effector in this setting.
Asunto(s)
Diferenciación Celular , Transición Epitelial-Mesenquimal , Osteoclastos/patología , Neoplasias Pancreáticas/patología , Antígenos CD/análisis , Baltimore , Biomarcadores de Tumor/análisis , Cadherinas/análisis , Humanos , Inmunohistoquímica , Italia , Estadificación de Neoplasias , Proteínas Nucleares/análisis , Osteoclastos/química , Neoplasias Pancreáticas/química , Neoplasias Pancreáticas/terapia , Estudios Retrospectivos , Factores de Transcripción de la Familia Snail/análisis , Proteína 1 Relacionada con Twist/análisisRESUMEN
Chemokines are a family of small proteins, subdivided by their conserved cysteine residues and common structural features. Chemokines interact with their cognate G-protein-coupled receptors to elicit downstream signals that result in cell migration, proliferation, and survival. This review presents evidence for how the various CXC and CC subfamily chemokines influence bone hemostasis by acting on osteoclasts, osteoblasts, and progenitor cells. Also discussed are the ways in which chemokines contribute to bone loss as a result of inflammatory diseases such as rheumatoid arthritis, HIV infection, and periodontal infection. Both positive and negative effects of chemokines on bone formation and bone loss are presented. In addition, the role of chemokines in altering the bone microenvironment through effects on angiogenesis and tumor invasion is discussed. Very few therapeutic agents that influence bone formation by targeting chemokines or chemokine receptors are available, although a few are currently being evaluated.
Asunto(s)
Quimiocinas/química , Infecciones por VIH , Huesos , Quimiocinas/inmunología , Humanos , Osteoblastos/química , Osteoblastos/fisiología , Osteoclastos/química , Osteoclastos/fisiologíaRESUMEN
Extracting sufficient quantity and quality RNA from bone is essential for downstream application, such as transcriptomic sequencing, to evaluate gene expression. Isolation of RNA from bone presents a unique challenge owing to the hypocellular, brittle and mineralized matrix, which makes homogenizing the tissue difficult and provides little RNA to work with. Removal of contaminating tissue, such as bone marrow and connective tissue, is essential for isolating RNA that is unique to osteoblasts, osteoclasts and osteocytes. This study established a method to effectively isolate RNA from normal canine bone cells using the phalanges, without contamination from other tissue types, for downstream transcriptomic analysis.
Asunto(s)
Huesos/química , Biología Molecular/métodos , ARN/aislamiento & purificación , Transcriptoma/genética , Animales , Perros , Regulación de la Expresión Génica/genética , Osteoblastos/química , Osteoclastos/química , Osteocitos/química , ARN/química , ARN/genéticaRESUMEN
Cytokines and hematopoietic growth factors have traditionally been thought of as regulators of the development and function of immune and blood cells. However, an ever-expanding number of these factors have been discovered to have major effects on bone cells and the development of the skeleton in health and disease (Table 1). In addition, several cytokines have been directly linked to the development of osteoporosis in both animal models and in patients. In order to understand the mechanisms regulating bone cells and how this may be dysregulated in disease states, it is necessary to appreciate the diverse effects that cytokines and inflammation have on osteoblasts, osteoclasts, and bone mass. This chapter provides a broad overview of this topic with extensive references so that, if desired, readers can access specific references to delve into individual topics in greater detail.
Asunto(s)
Citocinas , Osteoporosis , Animales , Huesos , Humanos , Osteoblastos/química , Osteoclastos/químicaRESUMEN
Prostaglandins (PGs) are highly bioactive fatty acids. PGs, especially prostaglandin E2 (PGE2), are abundantly produced by cells of both the bone-forming (osteoblast) lineage and the bone-resorbing (osteoclast) lineage. The inducible cyclooxygenase, COX-2, is largely responsible for most PGE2 production in bone, and once released, PGE2 is rapidly degraded in vivo. COX-2 is induced by multiple agonists - hormones, growth factors, and proinflammatory factors - and the resulting PGE2 may mediate, amplify, or, as we have recently shown for parathyroid hormone (PTH), inhibit responses to these agonists. In vitro, PGE2 can directly stimulate osteoblast differentiation and, indirectly via stimulation of RANKL in osteoblastic cells, stimulate the differentiation of osteoclasts. The net balance of these two effects of PGE2 in vivo on bone formation and bone resorption has been hard to predict and, as expected for such a widespread local factor, hard to study. Some of the complexity of PGE2 actions on bone can be explained by the fact that there are four receptors for PGE2 (EP1-4). Some of the major actions of PGE2 in vitro occur via EP2 and EP4, both of which can stimulate cAMP signaling, but there are other distinct signaling pathways, important in other tissues, which have not yet been fully elucidated in bone cells. Giving PGE2 or agonists of EP2 and EP4 to accelerate bone repair has been examined with positive results. Further studies to clarify the pathways of PGE2 action in bone may allow us to identify new and more effective ways to deliver the therapeutic benefits of PGE2 in skeletal disorders.
Asunto(s)
Resorción Ósea , Prostaglandinas , Humanos , Osteoclastos/química , Osteoclastos/fisiología , Subtipo EP4 de Receptores de Prostaglandina E/químicaRESUMEN
ß-TCP is a resorbable bony biomaterial but its biodegradation mechanisms in vivo remains unclear. Osteoclast can resorb ß-TCP but a role for macrophages has also been suggested by in vivo studies. However no in vitro study has clearly evidenced the action of macrophages in the resorption process. We prepared flat ß-TCP tablets with a smooth surface to investigate the in vitro capability of murine (RAW 264.7) and human macrophage cells (PBMCs) to resorb the biomaterial. In parallel, these cells were differentiated into multinucleated osteoclasts with M-CSF and RANK-L. The action of these cells was evaluated by scanning electron microscopy and Raman microspectroscopy after a 21 day culture on the tablets. Human macrophages and osteoclasts derived from PBMCs appeared able to resorb ß-TCP by forming resorption pits at the surface of the flat tablets. RAW macrophages were unable to resorb ß-TCP but they exhibited this possibility when they have been differentiated into osteoclasts. These cells can engulf ß-TCP grains in their cytoplasm as evidenced by light and TEM microscopy with production of carbonic anhydrase (revealed by the immunogold technique in TEM). The resorbed areas were characterized by severe degradation of the grains showing speckled and stick-like aspects indicating a chemical corrosion. The effect was maximal at the grain boundaries which have a slightly different chemical composition. Changes in the Raman spectrum were observed between the resorbed and un-resorbed ß-TCP suggesting crystal modifications. In contrast, un-differentiated murine macrophages were not able to chemically attack ß-TCP and no resorption pit was observed. RAW cell is not a representative model of the macrophage-biomaterial interactions that occur in human. This in vitro study evidences that both human osteoclasts and macrophages represent active cell populations capable to resorb ß-TCP.
Asunto(s)
Fosfatos de Calcio/metabolismo , Macrófagos/metabolismo , Osteoclastos/metabolismo , Animales , Materiales Biocompatibles/metabolismo , Transporte Biológico , Células Cultivadas , Humanos , Macrófagos/química , Macrófagos/citología , Ratones , Microscopía Electrónica de Rastreo , Osteoclastos/química , Osteoclastos/citología , Espectrometría RamanRESUMEN
Osteoclast lysosomes secrete lytic enzymes into bone resorption lacunae, and sort the lysosomal proton pumping vacuolar-type ATPase (V-ATPase) to the plasma membrane to form the acidic environment required for bone digestion. The a3 isoform of V-ATPase is essential for outward trafficking of the secretory lysosomes and interacts physically with Rab7, a small GTPase that regulates trafficking of late endosomes and lysosomes, to recruit it to lysosomes. However, it is unclear whether organelle acidification by V-ATPase is required for the lysosome trafficking. Here, we showed that incubation of osteoclasts with the V-ATPase inhibitor bafilomycin A1 abolished the osteoclast-characteristic peripheral localization of secretory lysosomes, Rab7, and α-tubulin. Although bafilomycin A1 had little or no effect on Rab7 activation and its interaction with a3, treatment with the inhibitor significantly reduced the lysosomal localization of Rab7. Even constitutively active Rab7 did not localize to lysosomes in the presence of the inhibitor. These results suggest that organelle acidification by V-ATPase is required for localization of activated Rab7 to lysosomes.
Asunto(s)
Inhibidores Enzimáticos/farmacología , Lisosomas/efectos de los fármacos , Macrólidos/farmacología , Osteoclastos/efectos de los fármacos , ATPasas de Translocación de Protón Vacuolares/antagonistas & inhibidores , Proteínas de Unión al GTP rab/análisis , Animales , Transporte Biológico/efectos de los fármacos , Células HEK293 , Humanos , Lisosomas/química , Ratones Endogámicos C57BL , Osteoclastos/química , Tubulina (Proteína)/análisis , Proteínas de Unión a GTP rab7RESUMEN
Antibody-mediated blockade of cluster of differentiation 47 (CD47)-thrombospondin-1 (TSP-1) interactions blocks osteoclast formation in vitro and attenuates parathyroid hormone (PTH)-induced hypercalcemia in vivo in mice. Hypercalcemia in this model reflects increased bone resorption. TSP-1 has two cell-associated binding partners, CD47 and CD36. The roles of these two molecules in mediating the effects of TSP1 in osteoclasts are unclear. Osteoclast formation was attenuated but not absent when preosteoclasts isolated from CD47-/- mice were cocultured with WT osteoblasts. Suppressing CD36 in osteoclast progenitors also attenuated osteoclast formation. The hypercalcemic response to a PTH infusion was blunted in CD47-/-/CD36-/- (double knockout (DKO)) female mice but not CD47-/- mice or CD36-/- animals, supporting a role for both CD47 and CD36 in mediating this effect. Consistent with this, DKO osteoclasts had impaired resorptive activity when analyzed in vitro Inhibition of nitric oxide (NO) signaling is known to promote osteoclastogenesis, and TSP-1 suppresses NO production and signaling. An anti-TSP-1 antibody increased NO production in osteoclasts, and the inhibitory effect of anti-TSP-1 on osteoclastogenesis was completely rescued by l-nitroarginine methyl ester (l-NAME), a competitive NO synthase inhibitor. Supportive of an important role for CD36 in mediating the pro-osteoclastogenic effects of TSP-1, engaging CD36 with a synthetic agonist, p907, suppressed NO production in anti-TSP-1-treated cultures, allowing osteoclast maturation to occur. These results establish that CD36 and CD47 both participate in mediating the actions of TSP-1 in osteoclasts and establish a physiologically relevant cross-talk in bone tissue between these two molecules.
Asunto(s)
Antígenos CD36/genética , Antígeno CD47/genética , Óxido Nítrico/biosíntesis , Trombospondina 1/genética , Animales , Resorción Ósea/genética , Resorción Ósea/patología , Antígenos CD36/química , Antígeno CD47/química , Femenino , Hipercalcemia/genética , Hipercalcemia/patología , Proteínas de la Membrana/química , Proteínas de la Membrana/genética , Ratones , Ratones Noqueados , NG-Nitroarginina Metil Éster/administración & dosificación , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/química , Osteoclastos/química , Osteoclastos/efectos de los fármacos , Osteoclastos/metabolismo , Osteogénesis/genética , Hormona Paratiroidea/química , Hormona Paratiroidea/genética , Detección de Señal Psicológica , Transducción de Señal/efectos de los fármacos , Trombospondina 1/químicaRESUMEN
BACKGROUND: Breast carcinoma with osteoclast-like giant cells (OGCs) is infrequent, being most reported cased described as ductal invasive carcinomas. Invasive pleomorphic lobular carcinoma (PLC) is a distinct morphological variant of invasive lobular carcinoma characterized by higher nuclear atypia and pleomorphism than the classical type. In the best of our knowledge, a PLC with OGCs has not been previously reported. CASE PRESENTATION: We report the case of a 72-year-old woman presenting with a pleomorphic tumor of the left breast with a dense infiltration by OGCs and T lymphocytes with a 10:1 predominance of CD8+ over CD4+ cells. The diagnosis of a lymphoid or mesenchymal neoplasia was excluded after demonstrating keratin expression by the neoplastic cells. The absence of E-cadherin expression and the morphological features were consistent with the diagnosis PLC with OGCs. In addition, we demonstrated the deleterious mutation C.del866C in CDH1gene, but no mutations in any of the other 33 genes analyzed by next generation sequencing. CONCLUSIONS: Breast carcinoma with stromal osteoclast-like giant cells is a very rare tumor, for that reason, the use of the cytologic features and growth patterns in combination with immunohistochemically studies is mandatory for a correct diagnosis of lobular carcinoma. In addition, further studies are necessary to clarify the influence of OGCs in the prognosis of these patients.
Asunto(s)
Neoplasias de la Mama/patología , Carcinoma Lobular/patología , Células Gigantes/patología , Osteoclastos/patología , Anciano , Antígenos CD/análisis , Antígenos CD/genética , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/genética , Neoplasias de la Mama/química , Neoplasias de la Mama/genética , Neoplasias de la Mama/terapia , Cadherinas/análisis , Cadherinas/genética , Carcinoma Lobular/química , Carcinoma Lobular/genética , Carcinoma Lobular/terapia , Quimioterapia Adyuvante , Análisis Mutacional de ADN , Femenino , Células Gigantes/química , Humanos , Inmunohistoquímica , Queratinas/análisis , Linfocitos Infiltrantes de Tumor/química , Linfocitos Infiltrantes de Tumor/patología , Mastectomía , Mutación , Osteoclastos/química , Linfocitos T/química , Linfocitos T/patología , Resultado del TratamientoAsunto(s)
Mastocitosis/complicaciones , Fracturas de la Columna Vertebral/diagnóstico , Urticaria Pigmentosa/etiología , Femenino , Humanos , Persona de Mediana Edad , Osteoclastos/química , Osteoclastos/fisiología , Osteoporosis/complicaciones , Osteoporosis/fisiopatología , Radiografía/métodos , Fracturas de la Columna Vertebral/complicaciones , Fracturas de la Columna Vertebral/diagnóstico por imagen , Urticaria Pigmentosa/fisiopatologíaRESUMEN
Triggering receptor expressed on myeloid cells 2 (TREM2) is an immune receptor expressed on the surface of microglia, macrophages, dendritic cells, and osteoclasts. The R47H TREM2 variant is a significant risk factor for late-onset Alzheimer's disease (AD), and the molecular basis of R47H TREM2 loss of function is an emerging area of TREM2 biology. Here, we report three high-resolution structures of the extracellular ligand-binding domains (ECDs) of R47H TREM2, apo-WT, and phosphatidylserine (PS)-bound WT TREM2 at 1.8, 2.2, and 2.2 Å, respectively. The structures reveal that Arg47 plays a critical role in maintaining the structural features of the complementarity-determining region 2 (CDR2) loop and the putative positive ligand-interacting surface (PLIS), stabilizing conformations capable of ligand interaction. This is exemplified in the PS-bound structure, in which the CDR2 loop and PLIS drive critical interactions with PS via surfaces that are disrupted in the variant. Together with in vitro and in vivo characterization, our structural findings elucidate the molecular mechanism underlying loss of ligand binding, putative oligomerization, and functional activity of R47H TREM2. They also help unravel how decreased in vitro and in vivo stability of TREM2 contribute to loss of function in disease.
Asunto(s)
Enfermedad de Alzheimer/genética , Predisposición Genética a la Enfermedad , Glicoproteínas de Membrana/química , Proteínas Mutantes/química , Receptores Inmunológicos/química , Enfermedad de Alzheimer/patología , Cristalografía por Rayos X , Células Dendríticas/química , Células Dendríticas/patología , Variación Genética , Humanos , Ligandos , Macrófagos/química , Macrófagos/patología , Glicoproteínas de Membrana/genética , Microglía/química , Microglía/patología , Proteínas Mutantes/genética , Proteínas del Tejido Nervioso/química , Proteínas del Tejido Nervioso/genética , Osteoclastos/química , Osteoclastos/patología , Conformación Proteica , Dominios Proteicos/genética , Receptores Inmunológicos/genéticaRESUMEN
Bidirectional transcription has been proposed to play a role associated with enhancer activity. Transcripts called enhancer RNAs (eRNAs) play important roles in gene regulation; however, their roles in osteoclasts are unknown. To analyse eRNAs in osteoclasts comprehensively, we used cap-analysis of gene expression (CAGE) to detect adjacent transcription start sites (TSSs) that were distant from promoters for protein-coding gene expression. When comparing bidirectional TSSs between osteoclast precursors and osteoclasts, we found that bidirectional TSSs were located in the 5'-flanking regions of the Nrp2 and Dcstamp genes. We also detected bidirectional TSSs in the intron region of the Nfatc1 gene. To investigate the role of bidirectional transcription in osteoclasts, we performed loss of function analyses using the CRISPR/Cas9 system. Targeted deletion of the DNA regions between the bidirectional TSSs led to decreased expression of the bidirectional transcripts, as well as the protein-coding RNAs of Nrp2, Dcstamp, and Nfatc1, suggesting that these transcripts act as eRNAs. Furthermore, osteoclast differentiation was impaired by targeted deletion of bidirectional eRNA regions. The combined results show that eRNAs play important roles in osteoclastogenic gene regulation, and may therefore provide novel insights to elucidate the transcriptional mechanisms that control osteoclast differentiation.
Asunto(s)
Elementos de Facilitación Genéticos , Perfilación de la Expresión Génica/métodos , Osteoclastos/citología , Ligando RANK/farmacología , Caperuzas de ARN/metabolismo , Animales , Sistemas CRISPR-Cas , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Regulación de la Expresión Génica , Proteínas de la Membrana/genética , Ratones , Factores de Transcripción NFATC/genética , Neuropilina-2/genética , Osteoclastos/química , Osteoclastos/efectos de los fármacos , Regiones Promotoras Genéticas , Sitio de Iniciación de la TranscripciónRESUMEN
BACKGROUND: Malignant melanoma showing numerous osteoclast-like giant cells (OGCs) is an uncommon morphologic phenomenon, rarely mentioned in the cytologic literature. The few reported cases seem to have an aggressive clinical behavior. Although most findings support monocyte/macrophage differentiation, the exact nature of OGCs is not clear. CASE: A 57-year-old woman presented with an inguinal lymphadenopathy. Sixteen years before, cutaneous malignant melanoma of the lower limb had been excised. Needle aspiration revealed abundant neoplastic single cells as well as numerous multinucleated OGCs. Occasional neoplastic giant cells were also present. Nuclei of OGCs were monomorphic with oval morphology and were smaller than those of melanoma cells. The immunophenotype of OGCs (S100-, HMB45-, Melan-A-, SOX10-, Ki67-, CD163-, BRAF-, CD68+, MiTF+, p16+) was the expected for reactive OGCs of monocyte/macrophage origin. The tumor has shown an aggressive behavior with further metastases to the axillary lymph nodes and oral cavity. CONCLUSION: Numerous OGCs are a rare and relevant finding in malignant melanoma. Their presence should not induce confusion with other tumors rich in osteoclastic cells. Since a relevant number of OGCs in melanoma may mean a more aggressive behavior, and patients may benefit from specific treatments, their presence should be mentioned in the pathologic report.
Asunto(s)
Células Gigantes/patología , Melanoma/secundario , Neoplasias de la Boca/secundario , Osteoclastos/patología , Neoplasias Cutáneas/patología , Biomarcadores de Tumor/análisis , Biopsia con Aguja Fina , Femenino , Células Gigantes/química , Humanos , Inmunohistoquímica , Metástasis Linfática , Melanoma/química , Melanoma/terapia , Persona de Mediana Edad , Neoplasias de la Boca/química , Neoplasias de la Boca/terapia , Osteoclastos/química , Fenotipo , Neoplasias Cutáneas/química , Neoplasias Cutáneas/terapiaRESUMEN
Fluorescent molecules are widely used as a tool to directly visualize target biomolecules in vivo. Fluorescent probes have the advantage that desired function can be rendered based on rational design. For bone-imaging fluorescent probes in vivo, they should be delivered to bone tissue upon administration. Recently, a fluorescent probe for detecting osteoclast activity was developed. The fluorescent probe has acid-sensitive fluorescence property, specific delivery to bone tissue, and durability against laser irradiation, which enabled real-time intravital imaging of bone-resorbing osteoclasts for a long period of time.
Asunto(s)
Huesos/química , Colorantes Fluorescentes/análisis , Imagen Molecular/métodos , Osteoclastos/química , Animales , Supervivencia Celular , Colorantes Fluorescentes/química , Osteoclastos/citologíaRESUMEN
The complex microenvironment that surrounds hematopoietic stem cells (HSCs) in the bone marrow niche involves different coordinated signaling pathways. The stem cells establish permanent interactions with distinct cell types such as mesenchymal stromal cells, osteoblasts, osteoclasts or endothelial cells and with secreted regulators such as growth factors, cytokines, chemokines and their receptors. These interactions are mediated through adhesion to extracellular matrix compounds also. All these signaling pathways are important for stem cell fates such as self-renewal, proliferation or differentiation, homing and mobilization, as well as for remodeling of the niche. Among these complex molecular cues, this review focuses on heparan sulfate (HS) structures and functions and on the role of enzymes involved in their biosynthesis and turnover. HS associated to core protein, constitute the superfamily of heparan sulfate proteoglycans (HSPGs) present on the cell surface and in the extracellular matrix of all tissues. The key regulatory effects of major medullar HSPGs are described, focusing on their roles in the interactions between hematopoietic stem cells and their endosteal niche, and on their ability to interact with Heparin Binding Proteins (HBPs). Finally, according to the relevance of HS moieties effects on this complex medullar niche, we describe recent data that identify HS mimetics or sulfated HS signatures as new glycanic tools and targets, respectively, for hematopoietic and mesenchymal stem cell based therapeutic applications.
Asunto(s)
Citocinas/química , Proteínas de la Matriz Extracelular/química , Células Madre Hematopoyéticas/química , Heparitina Sulfato/química , Células Madre Mesenquimatosas/química , Receptores de Citocinas/química , Animales , Materiales Biomiméticos/farmacología , Médula Ósea/fisiología , Conformación de Carbohidratos , Secuencia de Carbohidratos , Citocinas/metabolismo , Células Endoteliales/química , Células Endoteliales/metabolismo , Proteínas de la Matriz Extracelular/metabolismo , Células Madre Hematopoyéticas/efectos de los fármacos , Células Madre Hematopoyéticas/metabolismo , Heparitina Sulfato/clasificación , Heparitina Sulfato/metabolismo , Humanos , Células Madre Mesenquimatosas/efectos de los fármacos , Células Madre Mesenquimatosas/metabolismo , Osteoblastos/química , Osteoblastos/metabolismo , Osteoclastos/química , Osteoclastos/metabolismo , Unión Proteica , Receptores de Citocinas/metabolismo , Transducción de Señal , Nicho de Células Madre/fisiologíaRESUMEN
An effervescent pipette tip solid phase microextraction based on carbon nanotube-polymer composite microspheres was developed for the simultaneous extraction and determination of four alkaloids (magnoflorine, epiberberine, palmatine, and jatrorrhizine) and four flavonoids (epimedin A/B/C and icariin) from Epimedii herba in biological samples. In this work, the polymeric sorbent was prepared by incorporating carbon nanotube in sulfonated polystyrene-divinylbenzene microspheres. During the extraction, the dispersion of the sorbents at milligram level was achieved by the in situ generation of carbon dioxide. The effervescence enhanced the interaction between the sorbent and the analytes. Langmuir and Freundlich models were used to evaluate adsorption processes. Under the optimum analytical conditions, the method showed good linearity (3-300µgL-1), acceptable precision (RSD <5%), low limits of quantification (1.02-2.98µgL-1) and satisfactory recoveries (90.05-99.85%). The proposed method was successfully applied to the analysis of alkaloids and flavonoids from Epimedii herba in cell culture fluids, rat urine and feces obtained at the different time intervals.